| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology (E.v.d.B., G.J.B.), Rudolf Magnus Institute of Neuroscience, University Medical Center, Utrecht, and Departments of Gerontology and Geriatrics (A.J.M.d.C., R.G.J.W.) and Public Health and Primary Care (J.G.), Leiden University Medical Center, the Netherlands.
Address correspondence and reprint requests to E. van den Berg, Department of Neurology G03.228, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands e.vandenberg-6{at}umcutrecht.nl
Background: The metabolic syndrome is a cluster of risk factors including hypertension, obesity, dyslipidemia, and impaired glucose metabolism, associated with cardiovascular disease. The metabolic syndrome also appears to predispose to cognitive dysfunction and dementia. In this study the association between the metabolic syndrome and cognitive function was examined in a population of the oldest old.
Methods: The Leiden 85-Plus Study is a population-based study of 599 persons from age 85 onward. Cognitive function was assessed annually from age 85 to 90 by means of four neuropsychological tests. The presence (n = 237) or absence (n = 325) of the metabolic syndrome was recorded at baseline. Cross-sectional and prospective associations between the metabolic syndrome and cognitive function were analyzed with linear mixed models, adjusted for sex and level of education.
Results: At age 85 the metabolic syndrome was not associated with lower cognitive performance. The metabolic syndrome was associated with a decelerated cognitive decline from age 85 to 90 on the Mini-Mental State Examination (additional annual effect 0.18 [0.07], p = 0.01), the Stroop Test (–1.49 [0.59], p = 0.01), and the Letter Digit Coding Test (0.26 [0.09], p = 0.005). This effect was mainly attributable to glucose, body mass index, and, to a lesser extent, blood pressure.
Conclusion: The association between the metabolic syndrome and accelerated cognitive decline, which has been reported in persons up to age 75, is not evident in a population of the oldest old. The concept of the metabolic syndrome may be less valid in this age group.
Funded by unrestricted grants from the Netherlands Organisation of Scientific Research (ZonMw) and the Ministry of Health, Welfare and Sports. The research of G.J. Biessels and E. van den Berg was supported by grant 2003.01.004 of the Dutch Diabetes Research Foundation.
Disclosure: The authors report no conflicts of interest.
Received January 3, 2007. Accepted in final form April 5, 2007.
This article has been cited by other articles:
|
|
 |
|
  D. S. Knopman Mediterranean Diet and Late-Life Cognitive Impairment: A Taste of Benefit JAMA, August 12, 2009; 302(6): 686 - 687. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Terre Cognitive Risks of Dyslipidemia American Journal of Lifestyle Medicine, July 1, 2009; 3(4): 284 - 286. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Yaffe, A. L. Weston, T. Blackwell, and K. A. Krueger The Metabolic Syndrome and Development of Cognitive Impairment Among Older Women Arch Neurol, March 1, 2009; 66(3): 324 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Silverman, M. S. Beeri, J. Schmeidler, C. Rosendorff, G. Angelo, R. S. Mavris, H. T. Grossman, G. A. Elder, J. Carrion-Baralt, and R. West C-reactive protein and memory function suggest antagonistic pleiotropy in very old nondemented subjects Age Ageing, March 1, 2009; 38(2): 237 - 241. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
